Neonatal screening or screening of newborns means screening during the first few days of the child’s life to detect congenital metabolic defects and certain disorders that may hinder the child’s normal development. The disorders are not visible at birth, but have the potential to cause permanent neurological, cognitive, tactile and physical damages in the child. Early detection of these diseases enables early intervention to prevent long-term problems.
Labsystems provides a wide range of screening instruments, including modular and fully automated NBS instruments, manual and automated equipment and reagents. Labsystems Diagnostics OY is one of the foremost in the world in terms of New Born Screening Technology.
Click here to read more.